FDA Drug Recalls

Recalls / Class II

Class IID-0512-2021

Product

Banophen Diphenhydramine HCl 25 mg Antihistamine 100 capsules NDC 0904-5306-60 Distributed by: Major Pharmaceuticals 31778 Enterprise Drive Livonia, MI 48150 USA

Brand name
Diphenhydramine Hydrochloride
Generic name
Diphenhydramine Hydrochloride
Active ingredient
Diphenhydramine Hydrochloride
Route
Oral
NDCs
0904-2056, 0904-5306, 0904-2035
FDA application
M012
Affected lot / code info
All Lots distributed 02/23/2021 through 03/10/2021

Why it was recalled

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Recalling firm

Firm
Cardinal Health Inc.
Manufacturer
Major Pharmaceuticals
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
7000 Cardinal Pl, N/A, Dublin, Ohio 43017-1091

Distribution

Quantity
88 bottles
Distribution pattern
FL, GA, SC

Timeline

Recall initiated
2021-03-15
FDA classified
2021-05-24
Posted by FDA
2021-06-02
Terminated
2024-06-17
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0512-2021. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Diphenhydramine Hydrochloride · FDA Drug Recalls